JOSEPH D. CECCOLI - Corporate Board Profile

APPLIED DNA SCIENCES INC

Filing Date	Source Excerpt
2015-05-06	Joseph D. Ceccoli was appointed to the Board of Directors on December 3, 2014. Since 2010, Mr. Ceccoli has been the Founder, President and CEO of Biocogent, LLC, a bioscience company located at the Stony Brook Long Island High Technology Incubator. Our Board believes that Mr. Ceccoli’s professional, operational and management experience make him an important contributor to our Board. During the fiscal year ended September 30, 2014, we did not provide any cash compensation to our non-employee directors for their service on our Board of Directors.
2016-04-21	Joseph D. Ceccoli was appointed to the Board of Directors on December 3, 2014. Since 2010, Mr. Ceccoli has been the Founder, President and CEO of Biocogent, LLC, a bioscience company located at the Stony Brook Long Island High Technology Incubator. Biocogent is focused on the invention, development and commercialization of skin-active molecules and treatment products used in regulated (over-the-counter / med-care), personal care and consumer products. Prior to starting Biocogent, Mr. Ceccoli was Global Director of Operations for BASF Corporation, a global Fortune 100 company and the world’s largest global chemical company, where he was responsible for the integration, operations and growth of domestic and overseas business units from 2007 to 2008. Prior to BASF, Mr. Ceccoli was a General Manager for Engelhard Corporation, a US based fortune 500 company and chief operating officer of Long Island-based The Collaborative Group from 2004 to 2007. Mr. Ceccoli holds a Bachelor of Science (“B.S.”) degree in Biotechnology from Rochester Institute of Technology and advanced professional training in various pharmaceutical sciences, emulsion chemistry, engineering and management disciplines. He is a member of numerous professional organizations such as the American Chemical Society and the Society of Cosmetic Chemists. Our Board believes that Mr. Ceccoli’s professional, operational and management experience make him an important contributor to our Board.
2017-01-26	Joseph D. Ceccoli was appointed to the Board of Directors on December 3, 2014. Since 2010, Mr. Ceccoli has been the Founder, President and CEO of Biocogent, LLC, a bioscience company located at the Stony Brook Long Island High Technology Incubator. Biocogent is focused on the invention, development and commercialization of skin-active molecules and treatment products used in regulated (over-the-counter / med-care), personal care and consumer products. Prior to starting Biocogent, Mr. Ceccoli was Global Director of Operations for BASF Corporation, a global Fortune 100 company and the world’s largest global chemical company, where he was responsible for the integration, operations and growth of domestic and overseas business units from 2007 to 2008. Prior to BASF, Mr. Ceccoli was a General Manager for Engelhard Corporation, a US based fortune 500 company and chief operating officer of Long Island-based The Collaborative Group from 2004 to 2007. Mr. Ceccoli holds a Bachelor of Science (“B.S.”) degree in Biotechnology from Rochester Institute of Technology and advanced professional training in various pharmaceutical sciences, emulsion chemistry, engineering and management disciplines. He is a member of numerous professional organizations such as the American Chemical Society and the Society of Cosmetic Chemists. Our Board believes that Mr. Ceccoli’s professional, operational and management experience make him an important contributor to our Board. The compensation committee held three formal meetings during fiscal 2016.
2018-01-16	Joseph D. Ceccoli was appointed to the Board of Directors on December 3, 2014... Mr. Ceccoli was appointed a member of the Compensation Committee. Mr. Ryan no longer serves on the Compensation Committee, effective March 2016.
2019-04-04	Joseph D. Ceccoli was appointed to the Board of Directors on December 3, 2014. Since 2010, Mr. Ceccoli has been the Founder, President and CEO of Biocogent, LLC ... Mr. Ceccoli’s experience as an executive officer and director of several bioscience and chemical companies and organizations led the Board of Directors to conclude that he should serve as a director of the Company. ... Compensation Committee ... Messrs. Bitzer, Ceccoli, and Shamash (Chairperson) served on the compensation committee during the fiscal year ended September 30, 2018. ... Director Compensation: Fiscal 2018 ... Joseph D. Ceccoli ... Option Awards ($) 87,500 ... Total ($) 87,500.
2019-10-08	Joseph D. Ceccoli
2020-08-03	Joseph D. Ceccoli was appointed to the Board of Directors on December 3, 2014. ... Mr. Ceccoli's experience as an executive officer and director of several bioscience and chemical companies and organizations led the Board of Directors to conclude that he should serve as a director of the Company. ... The audit committee of the Board of Directors ... Joseph Ceccoli ... The compensation committee ... Messrs. Bitzer, Ceccoli, and Shamash ...
2021-08-03	Joseph D. Ceccoli was appointed to the Board of Directors on December 3, 2014. ... Mr. Ceccoli’s experience as an executive officer and director of several bioscience and chemical companies and organizations led the Board of Directors to conclude that he should serve as a director of the Company. ... The membership of each of the audit committee, the compensation committee, and the nominating committee is composed, and was composed during the fiscal year ended September 30, 2020, entirely of independent directors. ... An option to purchase 13,606 shares of our common stock was granted to Mr. Ceccoli on May 22, 2020, at an exercise price of $11.04 per share. ... Director Compensation: Fiscal 2020 ... Mr. Ceccoli's total compensation was $135,000.
2022-07-29	Joseph D. Ceccoli has been a member of the Board of Directors since December 3, 2014. ... The Board of Directors believes that Mr. Ceccoli’s experience across the bioscience and chemical markets, including in global and U.S.-based operations and management, enriches our Board of Directors. Mr. Ceccoli’s experience as an executive officer and director of several bioscience and chemical companies and organizations led the Board of Directors to conclude that he should serve as a director of the Company.
2022-08-10	Joseph D. Ceccoli has been a member of the Board of Directors since December 3, 2014. ... Mr. Ceccoli was Global Director of Operations for BASF Corporation, a global Fortune 100 company ... The Board of Directors believes that Mr. Ceccoli’s experience across the bioscience and chemical markets, including in global and U.S.-based operations and management, enriches our Board of Directors. ... Messrs. Bitzer, Ceccoli, and Shamash served during the fiscal year ended September 30, 2021, and Messrs. Ceccoli and Shamash currently continue to serve, on the audit committee. ... Messrs. Bitzer, Ceccoli, and Shamash (Chairperson) served on the compensation committee during the fiscal year ended September 30, 2021, Messrs. Ceccoli and Shamash currently continue to serve on the compensation committee.
2023-08-08	Joseph D. Ceccoli has been a member of the Board of Directors since December 3, 2014. ... Mr. Ceccoli has been the Founder, President and CEO of Biocogent, LLC. ... The Board of Directors believes that Mr. Ceccoli’s experience across the bioscience and chemical markets, including in global and U.S.-based operations and management, enriches our Board of Directors. Mr. Ceccoli’s experience as an executive officer and director of several bioscience and chemical companies and organizations led the Board of Directors to conclude that he should serve as a director of the Company.
2024-03-14	Joseph D. Ceccoli Common Stock 171,091(5)
2024-08-21	Joseph D. Ceccoli has been a member of the Board of Directors since December 3, 2014. Since 2010, Mr. Ceccoli has been the Founder, President and CEO of Biocogent, LLC. The Board of Directors believes that Mr. Ceccoli’s experience across the bioscience and chemical markets, including in global and U.S.-based operations and management, enriches our Board of Directors.